<div id="readability-page-1"><div>Chacko Jacob Chief Executive Officer of Oric Pharmaceuticals Inc [ORIC] filed a Form 4 on December 17, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:<div><table><tbody><tr><th>Date</th><th>Transaction</th><th>Shares</th><th>Price</th><th>Value</th></tr><tr><td>12/15/25</td><td>Exercise</td><td>83,666</td><td>$0.00</td><td>N/A</td></tr><tr><td>12/16/25</td><td>Surrender(1)</td><td>33,374</td><td>$9.06</td><td>$302,368</td></tr></tbody></table></div>Ending Holdings: 581,711 - Direct<ul><li>(1)</li><li>Surrender of shares back to company to pay option exercise cost and/or resulting tax liability.</li></ul>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data. </div></div>

ORIC

CEO Chacko Jacob of Oric Pharmaceuticals Inc acquired 50,292 shares, as disclosed in a Form 4 filed with the SEC on December 17, 2025. The transaction included exercising 83,666 shares and surrendering 33,374 shares to cover option exercise costs and tax liabilities. Ending holdings are 581,711 shares directly.

CEO Chacko Acquires 50,292 Of Oric Pharmaceuticals Inc [ORIC]